CROSSJECT
Zeneo needle-free autoinjector Zepizure
- B2B
- B2G
- Has physical offices
- Publicly traded
- Manufacturing
- Hardware
- Sales-led purchase
About CROSSJECT
Develops and manufactures needle-free autoinjectors for emergency medication, including epileptic rescue therapy and other life-saving treatments.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51–250 employees
- Headquarters
- Dijon, Bourgogne, France
- Founded
- 2001
- Revenue
- €140KFY2025, publicly reported
- Website
- crossject.com
- linkedin.com/company/crossject
CROSSJECT at a glance
CROSSJECT is a B2B/B2G company in the Pharmaceutical Manufacturing industry, headquartered in Dijon, Bourgogne, France.
CROSSJECT was founded in 2001.
CROSSJECT has 51–250 employees.
CROSSJECT's revenue is €140K (FY2025, publicly reported).
Selling to companies like CROSSJECT?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies